Comparison of Clinical Outcomes in Fresh Cycle With Single Blastocyst Stage and Double Cleavage-stage Embryos: a Single-center, Non-blind, Randomized Controlled Study
Study Details
Study Description
Brief Summary
In traditional assisted reproductive technology (ART), choosing multiple embryo transfer to get a high clinical pregnancy rate while increasing the risk of multiple pregnancies. Research showed that the single-cleavage embryo transfer could not simultaneously meet the dual requirements of maintaining pregnancy rate and reducing the multiple pregnancy rate.The purpose of this study was to observe the clinical outcome between double cleavage embryo transfers and single blastocyst transfers in fresh cycle through RCT study with GnRH antagonist protocol.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
In traditional assisted reproductive technology (ART), choosing multiple embryo transfer to get a high clinical pregnancy rate while increasing the risk of multiple pregnancies. Research showed that in the fresh cleavage embryo transfer cycle, the clinical pregnancy rate increased with the increase of the number of high-quality embryos transferred, and so did the multiple pregnancy rate, suggesting that the single-cleavage embryo transfer could not simultaneously meet the dual requirements of maintaining pregnancy rate and reducing the multiple pregnancy rate. Compared with the embryo at cleavage stage, blastocyst culture is a process of survival of the fittest, which is physiologically more synchronized with endometrial development and can improve embryo implantation rate.
The existing clinical research analysis is mostly limited to the down-regulating regimen, while the RCT study of high-quality with GnRH antagonist protocol is few. Therefore, the purpose of this study was to observe the clinical outcome between double cleavage embryo transfers and single blastocyst transfers in fresh cycle through RCT study with GnRH antagonist protocol.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Other: Double Cleavage-stage Embryos transfer In group A, two embryos at cleavage stage were transplanted on the third day after oocyte retrieval. |
Procedure: double cleavage-stage or single blastocyst stage embryos transfer
Infertile women requesting in vitro fertilization treatment were randomly assigned to undergo transfer of either two cleavage-stage embryos or a single blastocyst-stage embryo.
|
| Other: Single Blastocyst Stage Embryos transfer Group B was graded by Gardner blastocyst grading method, and one blastocyst was transplanted on the 5th or 6th day after oocyte retrieval. |
Procedure: double cleavage-stage or single blastocyst stage embryos transfer
Infertile women requesting in vitro fertilization treatment were randomly assigned to undergo transfer of either two cleavage-stage embryos or a single blastocyst-stage embryo.
|
Outcome Measures
Primary Outcome Measures
- live birth rate per fresh transfer [2 year]
live birth, which was defined as the presence of a live fetus (or feti) after the 24th week of gestational age
Eligibility Criteria
Criteria
Inclusion Criteria:
-
patients with a diagnosis of primary or secondary infertility with a clinical indication for IVF/intracytoplasmic sperm injection (ICSI)
-
under 38 years of age
-
number of AFC≥6, AMH>1.1ng/ml
-
no adverse factors of fresh embryo transplantation (evaluation by an experienced reproductive physician)
-
number of available embryos(day 3)≥4
-
informed consent
Exclusion Criteria:
-
PGT
-
with adenomyosis, endometrial compression by uterine fibroids, intrauterine adhesion, endometrial polyps and other factors unsuitable for fresh cycle transplantation
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Women's Hospital School Of Medicine Zhejiang University
- ORGANON (SHANGHAI) PHARMACEUTICAL TECHNOLOGY CO., LTD.
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IRB-20220201-R